AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Glucose Monitoring in Treatment of Postprandial Hypoglycemia After Gastric Bypass Surgery

RecruitingNAAges 18 Years - anyAllSykehuset i Vestfold HF
💬

In plain words

What the trial is, and whether it could suit you

The goal of this clinical trial is to learn if continuous glucose monitoring works to treat postprandial hypoglycaemia in patients who have undergone gastric bypass surgery. The main question it aims to answer is: • Is continuous glucose monitoring superior to usual care for prevention of postprandial hypoglycaemia in patients with verified postprandial hypoglycaemia after gastric bypass surgery? Researchers will compare continuous glucose monitoring to usual care to see if continuous glucose monitoring works to treat postprandial hypoglycaemia. Participants will: * Use a continuous glucose monitor for 6 weeks or use no continuous glucose monitor for 5 weeks and wear a blinded continuous glucose monitor for 1 week. * Visit the clinic 2-3 times and have 2-3 phone consultations. * Register symptoms of hypoglycaemia, answer questionnaires, undergo a 24-hour dietary recall interview cond

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: * Gastric bypass surgery at least 1 year ago * Age ≥18 years * Symptomatic postprandial hypoglycaemia; capillary glucose level \<3.0 mmol/L 1-4 hours after meals Exclusion Criteria: * Not able to give informed consent * Reduced compliance due to severe mental and psychiatric conditions * Use of insulin or sulfonylureas * Use of systemic corticosteroids * Primary or secondary adrenal insufficiency * Insulinoma * Severe heart-, lung, liver- or kidney disease, cancer, malnutrition and other medical conditions causing fragility * Performed bariatric revisional surgery * Drug- or alcohol abuse * Pregnancy * Use of acarbose or octreotide in the treatment of postprandial hypoglycemia * Use of continuous glucose monitor
💊

What it tests

  • Continuous glucose monitor (Dexcom® G7)
📍

Where

1 site
1Department of Endocrinology, Obesity and Nutrition, Vestfold Hospital Trust
Tønsberg, Norway
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy